J. Safra Sarasin Holding AG Acquires 231 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

J. Safra Sarasin Holding AG lifted its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 1.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,098 shares of the company’s stock after purchasing an additional 231 shares during the period. J. Safra Sarasin Holding AG’s holdings in Henry Schein were worth $1,529,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Invesco Ltd. increased its position in Henry Schein by 0.4% in the fourth quarter. Invesco Ltd. now owns 4,963,409 shares of the company’s stock worth $343,468,000 after buying an additional 17,552 shares in the last quarter. FMR LLC increased its holdings in Henry Schein by 6.6% in the 4th quarter. FMR LLC now owns 3,498,033 shares of the company’s stock worth $242,064,000 after acquiring an additional 217,143 shares in the last quarter. Geode Capital Management LLC increased its holdings in Henry Schein by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company’s stock worth $218,762,000 after acquiring an additional 14,876 shares in the last quarter. Fiduciary Management Inc. WI raised its stake in Henry Schein by 7.2% during the 4th quarter. Fiduciary Management Inc. WI now owns 2,488,335 shares of the company’s stock worth $172,193,000 after acquiring an additional 167,990 shares during the period. Finally, Dimensional Fund Advisors LP lifted its holdings in Henry Schein by 15.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,137,549 shares of the company’s stock valued at $147,920,000 after purchasing an additional 279,507 shares in the last quarter. 96.62% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on HSIC. Jefferies Financial Group increased their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Wells Fargo & Company started coverage on Henry Schein in a research report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price objective on the stock. Barrington Research reissued an “outperform” rating and set a $90.00 target price on shares of Henry Schein in a research note on Wednesday, February 26th. StockNews.com downgraded Henry Schein from a “buy” rating to a “hold” rating in a research note on Thursday, April 17th. Finally, Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and increased their price objective for the company from $69.00 to $84.00 in a report on Monday, January 6th. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $81.10.

Insider Activity

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the firm’s stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now owns 62,688 shares of the company’s stock, valued at $4,460,251.20. This trade represents a 6.05 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the company’s stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the transaction, the director now directly owns 24,805 shares in the company, valued at approximately $1,762,147.20. This represents a 9.50 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.

Henry Schein Price Performance

Henry Schein stock opened at $64.54 on Wednesday. Henry Schein, Inc. has a 52-week low of $60.56 and a 52-week high of $82.49. The company has a market cap of $7.91 billion, a price-to-earnings ratio of 26.56, a PEG ratio of 2.13 and a beta of 0.84. The firm’s fifty day moving average is $69.87 and its 200 day moving average is $71.88. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same period in the previous year, the business posted $0.66 EPS. The firm’s revenue was up 5.8% on a year-over-year basis. Sell-side analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.